After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...
Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...
The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...
Spravato has been approved since 2019 for ... "This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers hope for the millions of ...
A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...
Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
Cognitive neuroscientist Eleanor Maguire, PhD, whose studies of London taxi drivers' brains helped transform memory research, ...
Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping like heck’
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.
If you suffer from allergies or sinus congestion, you might want to think twice before using this nasal spray. The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal ...
The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results